Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. First Horizon National Corporation
61.5% sales growth and 11.16% return on equity
First Horizon National Corporation operates as the bank holding company for First Horizon Bank that provides various financial services.
First Horizon National Corporation's sales growth this year is expected to be 51.8% and 7.6% for next year.
Year-on-year quarterly revenue growth grew by 62.2%, now sitting on 1.94B for the twelve trailing months.
First Horizon National Corporation's sales growth for the next quarter is 61.5%. The company's growth estimates for the current quarter and the next is a negative 29.8% and 540%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.16%.
Volatility
First Horizon National Corporation's last day, last week, and last month's average volatility was 4.25%, 3.24%, and 0.64%, respectively.
First Horizon National Corporation's last day, last week, and last month's high and low average amplitude percentage was 4.35%, 4.05%, and 2.75%, respectively.
First Horizon National Corporation's Stock Yearly Top and Bottom Value
First Horizon National Corporation's stock is valued at $14.65 at 16:22 EST, way under its 52-week high of $17.40 and way above its 52-week low of $6.27.
First Horizon National Corporation's Moving Average
First Horizon National Corporation's value is way higher than its 50-day moving average of $12.84 and way above its 200-day moving average of $10.62.
2. Randgold
20.3% sales growth and 14.43% return on equity
Barrick Gold Corporation engages in the exploration, mine development, production, and sale of gold and copper properties.
Randgold's sales growth this year is anticipated to be 29% and 5.6% for next year.
Year-on-year quarterly revenue growth grew by 32.2%, now sitting on 12.2B for the twelve trailing months.
Randgold's sales growth for the next quarter is 20.3%. The company's growth estimates for the present quarter and the next is 100% and 118.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.43%.
Volatility
Randgold's last day, last week, and last month's average volatility was a positive 0.25%, a negative 0.76%, and a positive 0.15%, respectively.
Randgold's last day, last week, and last month's high and low average amplitude percentage was 1.75%, 2.22%, and 2.53%, respectively.
Randgold's Stock Yearly Top and Bottom Value
Randgold's stock is valued at $23.68 at 16:22 EST, way below its 52-week high of $31.22 and way higher than its 52-week low of $12.65.
Randgold's Moving Average
Randgold's value is above its 50-day moving average of $23.39 and way below its 200-day moving average of $26.74.
3. BioLife Solutions, Inc.
28.2% sales growth and 5.9% return on equity
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally.
BioLife Solutions, Inc.'s sales growth this year is expected to be 71.2% and 48.2% for next year.
Year-on-year quarterly revenue growth grew by 70.8%, now sitting on 41.66M for the twelve trailing months.
BioLife Solutions, Inc.'s sales growth for the next quarter is 28.2%. The company's growth estimates for the present quarter and the next is a negative 200% and negative -100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.9%.
Volatility
BioLife Solutions, Inc.'s last day, last week, and last month's average volatility was a negative 0.42%, a positive 0.45%, and a positive 0.44%, respectively.
BioLife Solutions, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 7.30%, 7.46%, and 6.25%, respectively.
BioLife Solutions, Inc.'s Stock Yearly Top and Bottom Value
BioLife Solutions, Inc.'s stock is valued at $40.80 at 16:22 EST, way under its 52-week high of $47.22 and way higher than its 52-week low of $7.37.
BioLife Solutions, Inc.'s Moving Average
BioLife Solutions, Inc.'s worth is higher than its 50-day moving average of $39.80 and way above its 200-day moving average of $27.91.
4. Electronic Arts Inc.
9% sales growth and 17.25% return on equity
Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets worldwide.
Electronic Arts Inc.'s sales growth this year is anticipated to be 15.1% and 5.4% for next year.
Year-on-year quarterly revenue growth declined by 14.6%, now sitting on 5.59B for the twelve trailing months.
Electronic Arts Inc.'s sales growth is a negative 0% for the ongoing quarter and 9% for the next. The company's growth estimates for the ongoing quarter and the next is 17.1% and negative -7.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.25%.
Volatility
Electronic Arts Inc.'s last day, last week, and last month's average volatility was a positive 0.80%, a negative 0.25%, and a positive 0.34%, respectively.
Electronic Arts Inc.'s last day, last week, and last month's high and low average amplitude percentage was 1.48%, 2.63%, and 2.28%, respectively.
Electronic Arts Inc.'s Stock Yearly Top and Bottom Value
Electronic Arts Inc.'s stock is valued at $141.86 at 16:22 EST, under its 52-week high of $147.36 and way higher than its 52-week low of $85.69.
Electronic Arts Inc.'s Moving Average
Electronic Arts Inc.'s worth is higher than its 50-day moving average of $135.29 and higher than its 200-day moving average of $132.83.
Previous days news about Electronic Arts Inc.
According to Bloomberg Quint on Wednesday, 13 January, "Ubisoft Entertainment SA said it will develop a new Star Wars game, indicating a longtime exclusivity agreement for Electronic Arts Inc. on the Walt Disney Co. franchise will come to an end."
5. Veeva Systems Inc.
25.1% sales growth and 18.73% return on equity
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
Veeva Systems Inc.'s sales growth this year is anticipated to be 31.2% and 18.6% for next year.
Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 1.38B for the twelve trailing months.
Veeva Systems Inc.'s sales growth for the next quarter is 25.1%. The company's growth estimates for the present quarter and the next is 25.9% and 10.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.73%.
Volatility
Veeva Systems Inc.'s last day, last week, and last month's average volatility was 4.06%, 1.18%, and 0.33%, respectively.
Veeva Systems Inc.'s last day, last week, and last month's high and low average amplitude percentage was 3.89%, 3.17%, and 3.34%, respectively.
Veeva Systems Inc.'s Stock Yearly Top and Bottom Value
Veeva Systems Inc.'s stock is valued at $288.54 at 16:22 EST, under its 52-week high of $313.99 and way higher than its 52-week low of $118.11.
Veeva Systems Inc.'s Moving Average
Veeva Systems Inc.'s worth is higher than its 50-day moving average of $273.73 and above its 200-day moving average of $270.44.
6. Generac Holdlings Inc.
32.9% sales growth and 25.53% return on equity
Generac Holdings Inc. designs, manufactures, and sells power generation equipment, energy storage systems, and other power products for the residential, and light commercial and industrial markets worldwide.
Generac Holdlings Inc.'s sales growth this year is expected to be 11.4% and 17.5% for next year.
Year-on-year quarterly revenue growth grew by 16.7%, now sitting on 2.32B for the twelve trailing months.
Generac Holdlings Inc.'s sales growth for the next quarter is 32.9%. The company's growth estimates for the present quarter and the next is 28.8% and 72.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.53%.
Volatility
Generac Holdlings Inc.'s last day, last week, and last month's average volatility was 3.33%, 2.17%, and 0.97%, respectively.
Generac Holdlings Inc.'s last day, last week, and last month's high and low average amplitude percentage was 3.39%, 4.08%, and 4.09%, respectively.
Generac Holdlings Inc.'s Stock Yearly Top and Bottom Value
Generac Holdlings Inc.'s stock is valued at $252.50 at 16:22 EST, below its 52-week high of $260.00 and way above its 52-week low of $75.50.
Generac Holdlings Inc.'s Moving Average
Generac Holdlings Inc.'s worth is way higher than its 50-day moving average of $221.44 and way higher than its 200-day moving average of $187.63.
7. Laboratory Corporation of America Holdings
28.4% sales growth and 10.9% return on equity
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide.
Laboratory Corporation of America Holdings's sales growth this year is expected to be 16.3% and 3.7% for next year.
Year-on-year quarterly revenue growth grew by 33%, now sitting on 12.44B for the twelve trailing months.
Laboratory Corporation of America Holdings's sales growth for the next quarter is 28.4%. The company's growth estimates for the present quarter and the next is 155.9% and 141.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.9%.
Volatility
Laboratory Corporation of America Holdings's last day, last week, and last month's average volatility was a negative 2.22%, a positive 0.97%, and a positive 0.27%, respectively.
Laboratory Corporation of America Holdings's last day, last week, and last month's high and low average amplitude percentage was 4.29%, 3.19%, and 2.09%, respectively.
Laboratory Corporation of America Holdings's Stock Yearly Top and Bottom Value
Laboratory Corporation of America Holdings's stock is valued at $213.55 at 16:22 EST, below its 52-week high of $220.35 and way above its 52-week low of $98.02.
Laboratory Corporation of America Holdings's Moving Average
Laboratory Corporation of America Holdings's worth is above its 50-day moving average of $203.00 and way above its 200-day moving average of $191.79.
Previous days news about Laboratory Corporation of America Holdings
According to Business Insider on Monday, 11 January, "The key players operating in the global contract research organizations market are IQVIA Holdings Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Charles River Laboratories International, Inc. (U.S.), Wuxi Apptec Co., Ltd. "
8. T-Mobile US
70.9% sales growth and 5.95% return on equity
T-Mobile US, Inc., through its subsidiaries, provides wireless services for branded postpaid and prepaid, and wholesale customers in the United States, Puerto Rico, and the United States Virgin Islands.
T-Mobile US's sales growth this year is expected to be 50.5% and 15.3% for next year.
Year-on-year quarterly revenue growth grew by 74.2%, now sitting on 59.93B for the twelve trailing months.
T-Mobile US's sales growth for the next quarter is 70.9%. The company's growth estimates for the current quarter and the next is a negative 41.4% and negative -41.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.95%.
Volatility
T-Mobile US's last day, last week, and last month's average volatility was a negative 0.15%, a negative 0.48%, and a negative 0.10%, respectively.
T-Mobile US's last day, last week, and last month's high and low average amplitude percentage was 1.13%, 2.35%, and 1.93%, respectively.
T-Mobile US's Stock Yearly Top and Bottom Value
T-Mobile US's stock is valued at $125.25 at 16:22 EST, under its 52-week high of $135.54 and way above its 52-week low of $63.50.
T-Mobile US's Moving Average
T-Mobile US's worth is below its 50-day moving average of $131.81 and above its 200-day moving average of $117.86.
Previous days news about T-Mobile US
According to Bloomberg Quint on Tuesday, 12 January, "The company and wireless peers AT&T Inc. and T-Mobile US Inc. are spending billions of dollars in a race to create 5G networks that they hope will transform industries ranging from health care to entertainment."
According to Bloomberg Quint on Tuesday, 12 January, "The talks come as competitor T-Mobile US Inc. borrowed $3 billion in the bond market to help fund spectrum purchases, as communications providers are amping up their bids in an expensive battle. "
